Biotech · Private company
Arch Oncology
Track this companyFree. Adds Arch Oncology to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- AO-176Phase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- AO-176Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- AO-176 + DexPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- AO-176 + Dex + BortPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- AO-176 + PaclitaxelPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- AO-176 + PembrolizumabPhase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Study of AO-176 as Monotherapy and in Combination With Bortezomib/Dexamethasone in Relapsed/Refractory Multiple MyelomaPHASE1_PHASE2 · COMPLETED · started Nov 30, 2020ClinicalTrials.gov NCT04445701 · fetched Nov 12, 2026
- AO-176 in Multiple Solid Tumor MalignanciesPHASE1_PHASE2 · COMPLETED · started Feb 4, 2019ClinicalTrials.gov NCT03834948 · fetched Nov 12, 2026